HistrelinHormone TherapySafety Rating 9/10
Primary research areaCentral precocious puberty
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range50 mg implant lasting 12 months
AdministrationSubcutaneous implant
Safety9/10 · FDA-approved (Supprelin LA)
NCAA D1Banned
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Histrelin
Mechanism of action
GnRH agonist implant; 12-month sustained release
Safety profile
Implant site reactions, hot flashes, mood changes · Approved for precocious puberty and prostate cancer; implant; well-tolerated
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Histrelin below your target.
Related pages